Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Zentera Therapeutics is a biopharmaceutical company.
Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.
Yuanxin Huibao is a health insurance technology service provider.
Zion Pharma is a drug discovery platform.
Turnstone Biologics is a privately-held clinical stage biotech company.
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform.
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
Theseus Pharmaceuticals is a technology-based company.
Medical device supplier based in Shanghai.
Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.
Emendo is a biotechnology company
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.
BioNova Pharma biopharmaceutical company that develops treatments for cancer.
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
BioShin is a clinical stage biopharmaceutical company.
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical. The firm invests across 23 different industry categories.
Among tracked funding rounds, SAGE Therapeutics received $650.0M in a Post Ipo Equity round. OrbiMed's total known invested capital is $23.6B.
OrbiMed's average investment size is $104.0M across its portfolio of 289 companies.
Recent OrbiMed portfolio additions include XinThera, Zentera Therapeutics, Beijing Yuan Xin, Yuanxin Huibao, Zion Pharma. These companies were founded in 2020 or later.